Shield Therapeutics's total assets for Q2 2025 were £62.10M, an increase of 35.30% from the previous quarter. GB:STX total liabilities were £76.96M for the fiscal quarter, a 63.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.